Not Signed In -
Delavirdine |
Rescriptor |
Image:Delavirdine.png Delavirdine Systematic (IUPAC) name N-[2-[4-[3-(1-methylethylamino) pyridin-2-yl] piperazin-1-yl] carbonyl-1H-indol-5-yl] methanesulfonamide Identifiers CAS number 136817-59-9 ATC code J05AG02 PubChem 5625 DrugBank APRD00149 Chemical data Formula C22H28N6O3S Mol. weight 456.562 g/mol Pharmacokinetic data Bioavailability ? Protein binding 98% Metabolism ? Half life 5.8 hours Excretion ? Therapeutic considerations ...
Wikipedia - [full article]
Delavirdine Clinical Trials
- A Study of Delavirdine Used Together with Other Anti-HIV Drugs in HIV-Infected Patients
ClinicalTrials.gov Identifier: NCT00002401 - Completed
HIV Infections
- A Study of Delavirdine Mesylate in Combination with Other Anti-HIV Drugs in HIV-Infected Children and Babies
ClinicalTrials.gov Identifier: NCT00002210 - Completed
HIV Infections
- Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S)
ClinicalTrials.gov Identifier: NCT00000810 - Completed
HIV Infections
- A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients
ClinicalTrials.gov Identifier: NCT00002236 - Completed
HIV Infections
- A Double-Blind, Randomized, Comparative Study of Delavirdine Mesylate (U-90152S) in Combination With Didanosine (ddI) Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of <= 300/mm3
ClinicalTrials.gov Identifier: NCT00002123 - Completed
HIV Infections
- A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination with Zidovudine (ZDV) versus ZDV alone in HIV-1 Infected Individuals with CD4 Counts of 200-500mm3
ClinicalTrials.gov Identifier: NCT00002124 - Completed
HIV Infections
- Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination with Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects
ClinicalTrials.gov Identifier: NCT00000882 - Completed
HIV Infections
- A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination Therapy
ClinicalTrials.gov Identifier: NCT00000803 - Completed
HIV Infections
- The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success with Protease Inhibitors
ClinicalTrials.gov Identifier: NCT00002420 - Terminated
HIV Infections
- A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients
ClinicalTrials.gov Identifier: NCT00001094 - Terminated
HIV Infections
- A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients
ClinicalTrials.gov Identifier: NCT00002400 - Completed
HIV Infections
- Safety and Effectiveness of Giving Combinations of Three or Four Anti-HIV Drugs to HIV-Infected Patients
ClinicalTrials.gov Identifier: NCT00002211 - Completed
HIV Infections
- A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir
ClinicalTrials.gov Identifier: NCT00000892 - Completed
HIV Infections
- The Safety and Effectiveness of U-90152 in HIV-1 Infected Patients Who Take Zidovudine
ClinicalTrials.gov Identifier: NCT00002312 - Completed
HIV Infections
- Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects with Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315
ClinicalTrials.gov Identifier: NCT00000891 - Completed
HIV Infections
- A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients
ClinicalTrials.gov Identifier: NCT00002378 - Completed
HIV Infections
- A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination with Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive Patients
ClinicalTrials.gov Identifier: NCT00002178 - Completed
HIV Infections
- Safety and Effectiveness of 3 Anti-HIV Treatments in Patients Who Have Failed Previous Treatments Containing Nelfinavir
ClinicalTrials.gov Identifier: NCT00006326 - Terminated
HIV Infections
Resources
- Delavirdine (Drug Digest)
- Rescriptor (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
